ACTC Stock Quote and News
ACTC Stock Bio
Advanced Cell Technology Inc., a biotechnology company, specializes in developing cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide.
ACTC Management
Gary Rabin – Interim CEO, Chariman
ACTC Stock Overview
ACTC has been trading in a range from $0.17 – 0.22 over the past few months. There have been some decent intraday moves in though. The last big move for ACTC came in late March where it went from $0.16 to $0.22.
ACTC News
- ADVANCED CELL TECHNOLOGY, INC. Financials
- Biotech Companies Look to Benefit From Transformed Patent System
- ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
- Advanced Cell Technology Announces 2012 First Quarter Results
- ADVANCED CELL TECHNOLOGY, INC. Files SEC form 10-Q, Quarterly Report

Comments on this entry are closed.